ReviewFrontiers in cell and developmental biology2026
The emerging roles of microRNAs in pneumoconiosis: pathogenic mechanisms and clinical implications.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pneumoconiosis is currently one of the most common occupational diseases in clinical practice. Its pathogenesis has not yet been fully elucidated, and effective clinical treatments are lacking. MicroRNAs (miRNAs) are a class of non-coding single-stranded RNA molecules that regulate gene expression at the post-transcriptional level by binding to target genes, thereby inhibiting mRNA translation or promoting mRNA degradation. Existing studies have shown that miRNAs are closely associated with the development and progression of pneumoconiosis, making them important candidate biomarkers for early screening and diagnosis of the disease. This review summarizes the current research status and advances regarding miRNAs in pneumoconiosis, aiming to provide new insights and approaches for understanding its pathogenesis, as well as for early warning, diagnosis, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.